Advertisement

Topics

sanofi-aventis/Bristol-Myers Squibb Partnership Company Profile

06:31 EST 23rd November 2017 | BioPortfolio


News Articles [1450 Associated News Articles listed on BioPortfolio]

Head-To-Head Survey: Bristol-Myers Squibb (BMY) & Its Competitors

Bristol-Myers Squibb is one of 113 publicly-traded companies in the "Pharmaceuticals" industry, but how does it weigh in compared to its rivals? We will compare Bristol-Myers Squibb to similar busines...

Bristol-Myers Squibb Extends Strategic Partnership With TARGET Pharmasolutions For TARGET-NASH

CHAPEL HILL, N.C, Oct. 12, 2017 /PRNewswire/ --TARGET PharmaSolutions, Inc., a real-world clinical data company, is pleased to announce that Bristol-Myers Squibb (BMY) has extended its strategic partn...

Bristol-Myers Squibb Extends Partnership with Target PharmaSolutions for TARGET-NASH

CHAPEL HILL, N.C, Oct. 12, 2017 /PRNewswire/ — TARGET PharmaSolutions, Inc., a real-world clinical data company, is pleased to announce that Bristol-Myers Squibb (BMY) has extended its strategic...

Investment Analysts' Weekly Ratings Updates for Bristol-Myers Squibb

Several brokerages have updated their recommendations and price targets on shares of Bristol-Myers Squibb in the last few weeks: 9/19/2017 - Bristol-Myers Squibb had its "hold" rating reaffirmed by an...

Research Analysts' Weekly Ratings Changes for Bristol-Myers Squibb

A number of firms have modified their ratings and price targets on shares of Bristol-Myers Squibb recently: 7/27/2017 - Bristol-Myers Squibb was given a new $60.00 price target on by analysts at Piper...

Bristol-Myers Squibb To Acquire IFM Therapeutics

NEW YORK CITY (dpa-AFX) - Bristol-Myers Squibb Company (BMY) and IFM Therapeutics announced the companies have signed an agreement under which Bristol-Myers Squibb will acquire all of the outstand...

Bristol-Myers Squibb, Syngene International expand ongoing research collaboration

Bengaluru , Nov 14 : To undertake a greater range of scientific research and development for pharmaceuticals across a broader range of activities, Syngene International, India's contract research ...

Bristol-Myers Squibb Brings Out Its Ace Card In The Midst Of An IDO Inhibitor Battle

Bristol-Myers Squibb released positive results in an early-stage study using an IDO inhibitor drug in combination with Opdivo in both bladder and cervical cancer patients. Recently, Bristol-Myers Squi...

PubMed Articles [231 Associated PubMed Articles listed on BioPortfolio]

Treatment of Ipilimumab-Induced Vogt-Koyanagi-Harada Syndrome With Oral Dexamethasone.

The author presents a retrospective case report of a 54-year-old male with ipilimumab (Yervoy; Bristol-Myers Squibb, New York City, NY)-induced Vogt-Koyanagi-Harada Disease (VKH), which consisted of u...

Safety and Efficacy of Ziv-Aflibercept in the Treatment of Refractory Diabetic Macular Edema.

To evaluate the safety and efficacy of ziv-aflibercept (Zaltrap; Sanofi-Aventis, Bridgewater, NJ/Regeneron Pharmaceuticals, Tarrytown, NY) in the treatment of refractory diabetic macular edema (DME).

A Systematic Review and Pooled Analysis of Select Safety Parameters Among Normal Healthy Volunteers Taking Placebo in Phase 1 Clinical Trials.

A systematic review of the Bristol-Myers Squibb normal healthy volunteers (NHVs) database identified phase 1 trials that included NHVs administered placebo with the aim of characterizing normal inter-...

Update: Temporary Total Depletion of U.S. Licensed Yellow Fever Vaccine for Civilian Travelers Addressed by Investigational New Drug Use of Imported Stamaril Vaccine.

Sanofi Pasteur, the manufacturer of the only yellow fever vaccine (YF-VAX) licensed in the United States, has announced that their stock of YF-VAX is totally depleted as of July 24, 2017. YF-VAX for c...

Partnership agreements less likely among young gay and bisexual men in Australia ? data from a national online survey of gay and bisexual men.

Background: How gay and bisexual men (GBM) establish partnership agreements may be affected by several factors, including age. The ability to communicate with a partner about sexual agreements has imp...

Clinical Trials [303 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Daclatasvir From Prodactariv 60 mg Film Coated Tablets (International Drug Agency for Pharmaceutical Industry (IDI), Egypt) and Clatazev 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Daclatasvir from Prodactariv 60 mg F.C.T (International Drug Agency for Pha...

Food Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg

The objective of this study was to investigate the bioequivalence of Mylan's clopidogrel bisulfate 75 mg tablets to Bristol-Myers Squibb/Sanofi's Plavix® 75 mg tablets following a single,...

Bioequivalence Study of Daclatasvir From Daktavira 60 mg Film Coated Tablets ( European Egyptian Pharmaceutical Industries, Egypt) Versus Daklinza 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Daclatasvir from Daktavira 60 mg film coated tablets ( European Egyptian Ph...

Fasting Study of Clopidogrel Bisulfate Tablets 75 mg to Plavix® Tablets 75 mg

The objective of this study was to investigate the bioequivalence of Mylan's clopidogrel bisulfate 75 mg tablets to Bristol-Myers Squibb/Sanofi's Plavix® 75 mg tablets following a single,...

Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fed, Healthy, Adult Subjects

- Objective: - A Randomized, Two-Way Crossover, Single-Dose, Open-Label Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Co...

Companies [748 Associated Companies listed on BioPortfolio]

Bristol-Myers Squibb & Sanofi-aventis

Sanofi-aventis U.S. is an affiliate of sanofi-aventis, a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to help improve the l...

sanofi-aventis/Bristol-Myers Squibb Partnership

Pfizer Inc. & Bristol-Myers Squibb

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize apixaban, an oral anticoagulant discovered by Bristol-Myers Squibb. Th...

Bristol-Myers Squibb and Pfizer

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize apixaban, an oral anticoagulant discovered by Bristol-Myers Squibb. Th...

Bristol-Myers Squibb Company and Pfizer Inc.

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize Eliquis, an oral anticoagulant discovered by Bristol-Myers Squibb. Thi...

More Information about "sanofi-aventis/Bristol-Myers Squibb Partnership" on BioPortfolio

We have published hundreds of sanofi-aventis/Bristol-Myers Squibb Partnership news stories on BioPortfolio along with dozens of sanofi-aventis/Bristol-Myers Squibb Partnership Clinical Trials and PubMed Articles about sanofi-aventis/Bristol-Myers Squibb Partnership for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of sanofi-aventis/Bristol-Myers Squibb Partnership Companies in our database. You can also find out about relevant sanofi-aventis/Bristol-Myers Squibb Partnership Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record